Sulpiride is a selective antagonist for dopamine D 2 receptors and is widely used in psychiatry for the treatment of schizophrenia, depression, and other related psychological disorders. It is also used in the treatment of gastric and duodenal ulcers. 3, 4) Sulpiride has a peptide bond and two ionizable species: the nitrogen of the pyrrolidine ring and the sulphamoyl group in its structure. We have speculated that the transport of sulpiride across the human intestine is mainly mediated by peptide transporters and organic cation transporters. In our previous paper, 5) we demonstrated that sulpiride uptake and efflux from apical membranes in Caco-2 cells was carrier mediated, and that the uptake is mediated by the peptide transporter PEPT1 and the organic cation transporters OCTN1 and OCTN2, and furthermore, the efflux might be mediated by P-glycoprotein.
The intestinal peptide transporter PEPT1 is localized at the brush-border membranes of epithelial cells and mediates the absorption of endogenous di-and tripeptides and various peptide-like drugs such as b-lactam antibiotics, 6 ) ACE inhibitors, 7) and antiherpetic agents. 8) Terada and coworkers 9) found that another peptide transporter was expressed in the basolateral membranes. The basolateral peptide transporter and PEPT1 cooperate in the efficient transepithelial transport of small peptides and peptide-like drugs from the cells to the circulating blood. Transport systems in the small intestine brush-border membrane and basolateral membrane for the absorption and secretion of organic cations have recently been reported and reviewed. 10, 11) It has also been shown that organic cation transporter systems are involved in the absorption and secretion of organic cations and that P-glycoprotein is involved in their secretion. 12) Caco-2 cells are commonly used in drug transport studies and have been evaluated as a transport model system of small intestinal epithelium. 13) Cells cultured on a permeable membrane permit the study of both the intracellular (apical-to-basolateral) and extracellular (basolateral-to-apical) transport of drugs. In the present study, we used Caco-2 cell monolayers cultured on a permeable membrane to clarify the transcellular transport system of sulpiride in the human intestine.
MATERIALS AND METHODS
Materials Sulpiride, cephalexin hydrate, 2-(N-morpholino)ethanesulfonic acid (MES), and N-2-hydroxyethylpiperazone-NЈ-2-ethanesulfonic acid (HEPES) were purchased from ICN Biomedicals Inc. (Costa Mesa, CA, U.S.A.). L-Carnitine, glycylsarcosine, Dulbecco's modified Eagle's medium (DMEM), nonessential amino acids, fetal bovine serum, penicillin-streptomycin solution (50X) and 0.25% trypsin-EDTA solution were purchased from Sigma (St. Louis, MO, U.S.A.). Captopril, choline chloride, cyclosporin A, quinidine, p-aminohippuric acid, verapamil hydrochloride, and nicotinic acid were purchased from Wako Pure Chemical Industries (Osaka, Japan). Guanidine was purchased from Kanto Chemical (Tokyo, Japan). All chemicals used were of the highest purity commercially available.
Cell Culture Caco-2 cells in passage 41 were obtained from the RIKEN Gene Bank (Tsukuba, Japan To determine the transport mechanism of sulpiride in an in vitro model of the human intestine, we investigated the transepithelial transport of this agent in Caco-2 cells. The transepithelial transport and intracellular accumulation of sulpiride were measured using Caco-2 cell monolayers cultured on a permeable membrane. The transepithelial transport of sulpiride in Caco-2 cells showed temperature dependence, and the transport was enhanced at weakly acidic pH on the apical side. These results demonstrate that the transepithelial transport of sulpiride is carrier mediated. To identify the drug transporter species that take part in the transepithelial transport of sulpiride, we examined the effects with the addition and preloading with specific substrates and inhibitors of various drug transporters. The results obtained from these examinations indicated that the apical-to-basolateral transport of sulpiride is mediated by the peptide transporter PEPT1, organic cation transporters OCTN1 and OCTN2 on the apical membrane, and the basolateral peptide transporter on the basolateral membrane. The basolateral-to-apical transport is mediated by the basolateral peptide transporter and organic cation transporter OCT1 on the basolateral membrane and by P-glycoprotein on the apical membrane. A decrease in the absorption of sulpiride may occur in coadministration protocols involving PEPT1-, OCTN1-, and OCTN2-transported drugs. Coadministration using the P-glycoprotein-transported drugs, in contrast, may enhance the absorption of sulpiride.
sages 45-55 were grown routinely on 75 cm 2 plastic culture flasks (Becton Dickinson, Franklin Lakes, NJ, U.S.A.) in DMEM containing 10% fetal bovine serum, 1% nonessential amino acids, streptomycin (100 mg/ml) and penicillin-G (100 U/ml) at 37°C in a 5% CO 2 /95% air atmosphere. The medium was replaced every 3-4 d after inoculation. Subculture was performed every 7 d using 0.25% trypsin/0.02% EDTA. For the transport studies, Caco-2 cells were seeded at a density of 3.5ϫ10 5 cells/permeable membrane (Cell Culture Insert, 0.45 mm, 4.3 cm 2 growth area, Becton Dickinson) in the above medium. Each permeable membrane was replaced in a Multiwell plate (6 wells, Becton Dickinson) with 2.2 ml of the basolateral side medium and 1.5 ml of the apical side medium. The medium was replaced every 3-4 d after inoculation. Caco-2 cell monolayers cultured for 14-16 d were used in the experiments. The quality of the monolayers grown on the permeable membrane was assessed by the transepithelial electrical resistances using Millicell-ERS (Millipore, Bedford, MA, U.S.A.). Resistances were more than 365 (391Ϯ17) W · cm 2 .
Transport Study of Sulpiride in Caco-2 Cell Monolayers
For the transport studies, the culture medium of both sides was removed by aspiration and the Caco-2 cell monolayers were washed twice with incubation medium consisting of 145 mM NaCl, 3 mM KCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 5 mM D-glucose, and 5 mM HEPES (pH 7.4, apical or basolateral side) or 5 mM MES (pH 6.0, apical side). After washing, the monolayers were preincubated for 10 min at 37°C with 1.5 ml (pH 6.0 or 7.4) and 2.2 ml (pH 7.4) of incubation medium on the apical and basolateral sides, respectively. After preincubation, the medium was removed and fresh incubation medium containing sulpiride (0.3 mM) was added to either the apical (1.5 ml) or basolateral side (2.2 ml). Incubation medium without sulpiride was then added to the opposite side (basolateral, 2.2 ml; apical, 1.5 ml). In the inhibition study (Table 1) , incubation medium containing sulpiride (0.3 mM) with or without various compounds was added to either the apical (1.5 ml) or basolateral side (2.2 ml), and incubation medium without sulpiride was added to the opposite side (basolateral, 2.2 ml; apical, 1.5 ml). In the trans-stimulation study (Table 2) , the incubation medium containing various substrates was added to both sides and the monolayers were preloaded for 30 min. After washing, incubation medium containing sulpiride (0.3 mM) was added to either the apical (1.5 ml) or basolateral side (2.2 ml), and incubation medium without sulpiride was added to the opposite side (basolateral, 2.2 ml; apical, 1.5 ml). The monolayers were then incubated for the time indicated at 37°C. Sulpiride was dissolved in dimethyl sulfoxide (DMSO) and other compounds were dissolved in DMSO or H 2 O. The final concentration of DMSO in the incubation medium was approximately 1%. After incubation, the medium on the opposite sides was transferred to a sample tube and filtered through a Millipore filter (Millex-LG, Millipore). Filtrate concentrations of sulpiride were determined by HPLC as described previously. 5) For the accumulation studies, the membrane filters were detached from the insert well after incubation, and then the cells were extracted with 0.5 ml of 30 mM phosphate buffer (pH 7.0)/acetonitrile (50/50, v/v) for 1 h. The extract was centrifuged at 3000 rpm for 20 min and the supernatant filtered through a Millipore filter. The filtrate was analyzed using HPLC.
Statistical Analysis Results are expressed as the meanϮS.D. Differences between the two groups were evaluated by Student's t-test or Welch's t-test after the initial analysis with the F-test. p values of less than 0.05 were considered significant.
RESULTS

Effects of pH and Temperature on Transepithelial Transport and Intracellular Accumulation of Sulpiride
The transepithelial transport and intracellular accumulation of sulpiride by Caco-2 cell monolayers were examined at pH 5.0, 6.0, 7.0, and 7.4 on the apical side, and at pH 7.4 on the basolateral side. As the result of preliminary study, the apical-to-basolateral transport of sulpiride showed linearity with 0.1-1.0 mM sulpiride concentration. Therefore the following studies were performed at 0.3 mM of sulpiride concentration. Effects of pH on the transepithelial transport and intracellular accumulation of sulpiride are shown in Fig. 1 . When sulpiride was added to either the apical or basolateral side of Caco-2 cell monolayers, the apical-to-basolateral transport of sulpiride and its intracellular accumulation from the apical membrane at pH 6.0 and 7.0 on the apical side were higher than those at pH 5.0 and 7.4 on the apical side. On the other hand, the basolateral-to-apical transport of sulpiride at pH 5.0, 6.0, and 7.0 on the apical side was higher than that at pH 7.4 on the apical side, and the intracellular accumulation of sulpiride from the basolateral membrane did not show pH dependence. We therefore performed the following experiments using the apical side medium at pH 6.0. The transepithelial transport of sulpiride from the apical membrane to basolateral membrane was significantly higher than that from the basolateral membrane to apical membrane. In addition, the intracellular accumulation of sulpiride from the apical side was significantly higher than that from the basolateral side. The apical-to-basolateral transport corresponds to the absorptive process in the intestinal mucosa. The transepithelial transport of sulpiride shows the dominant direction for absorption, because the apical-to-basolateral transport was higher than the basolateral-to-apical transport. 
Inhibitory Effects of Various Compounds on the Transepithelial Transport and Intracellular Accumulation of Sulpiride
To identify the transporter(s) responsible for the transepithelial transport of sulpiride, we studied the inhibitory effect of various well-known substrates and inhibitors (3 mM; except cephalexin, quinidine, and cyclosporin A for low solubility) of intestinal drug transporters on the transepithelial transport and intracellular accumulation of sulpiride (0.3 mM) by Caco-2 cell monolayers. In this experiment, incubation medium containing sulpiride with or without various substrates was added to either the apical or basolateral side, and incubation medium without sulpiride was added to the opposite side. As shown in Table 1 , the apicalto-basolateral transport of sulpiride and its intracellular accumulation from the apical side by Caco-2 cell monolayers were significantly and remarkably inhibited by the addition of captopril, 7) cephalexin, 6) and glycylsarcosine, 6) substrates of the peptide transporter PEPT1, and furthermore, L-carnitine, 14) substrate of organic cation transporters OCTN1 and OCTN2, and choline, 14, 15) inhibitor of organic cation transporters OCT1, OCTN1, and OCTN2. However, guanidine, 16) substrate of organic cation transporter OCT3, p-aminohippuric acid, 17) substrate of organic anion transporter AE2, nicotinic acid, 18) substrate of organic anion transporter AE2 and MCT1, quinidine and verapamil, 15, [19] [20] [21] substrates of Pglycoprotein and the organic cation transporters OCTN1, OCTN2, and OCT1 did not affect the apical-to-basolateral transport of sulpiride and its intracellular accumulation from the apical side. However, the apical-to-basolateral transport of sulpiride and its intracellular accumulation from the apical side by Caco-2 cell monolayers were significantly increased by the addition of cyclosporin A, 22) a typical substrate of Pglycoprotein. On the other hand, the basolateral-to-apical transport of sulpiride was significantly inhibited by the addition of choline, quinidine, verapamil, and cyclosporin A. The intracellular accumulation of sulpiride from the basolateral side was significantly inhibited by the addition of captopril, cephalexin, glycylsarcosine, choline, quinidine, and verapamil, although the accumulation was significantly increased by the addition of cyclosporin A.
trans-Stimulation Effects of Various Compounds on Transepithelial Transport and Intracellular Accumulation of Sulpiride
We then investigated the trans-stimulation effects of various well-known substrates and inhibitors of intestinal drug transporters on the transepithelial transport and the intracellular accumulation of sulpiride by Caco-2 cell monolayers. trans-Stimulation of the transepithelial transport by preloading with a structural analogue has also been observed in various drug transport systems, such as organic anion transporter, 23) organic cation transporter, 11) peptide transporter, 24) and P-glycoprotein. 25) The incubation medium containing various substrates was added to both the apical and basolateral sides, and the monolayers were preloaded for 30 min. As shown in Table 2 , the apical-to-basolateral transport of sulpiride and its intracellular accumulation from the apical side were significantly increased by preloading with captopril, cephalexin, glycylsarcosine, L-carnitine, and choline. The basolateral-to-apical transport of sulpiride was significantly increased by preloading with choline, quinidine, verapamil, and cyclosporin A. Moreover, the intracellular accumulation of sulpiride from the basolateral side was significantly increased by preloading with captopril, cephalexin, glycylsarcosine, choline, quinidine, and verapamil. Guanidine, p-aminohippuric acid, and nicotinic acid did not affect the transport and the intracellular accumulation of sulpiride.
DISCUSSION
Previously, we demonstrated that sulpiride uptake and efflux in Caco-2 cells were carrier mediated. 5) Naasani et al. 26) reported that sulpiride was extremely hydrophilic at pH 7.4 or less, and it was unlikely to be partitioned into lipophilic media. In the present study, the transepithelial transport and the intracellular accumulation of sulpiride by Caco-2 cell monolayers were temperature dependent and they were enhanced at weakly acidic pH on the apical side, excluding the intracellular accumulation of sulpiride from the basolateral side. It is clear from both previous 5) and current studies that the transport of sulpiride from the apical side is carrier mediated. On the basis of this study, the basolateral-to-apical transport of sulpiride is also carrier mediated.
To identify the drug transporter species that take part in the transepithelial transport of sulpiride in the present study, we investigated the effect of the addition (Table 1) and preloading (Table 2 ) of various specific drug transporter substrates on the transepithelial transport of sulpiride. The results are summarized as follows. The apical-to-basolateral transport of sulpiride and its intracellular accumulation from the apical side in Caco-2 cell monolayers were significantly and remarkably inhibited by the addition of captopril, cephalexin, and glycylsarcosine, substrates of peptide transporter PEPT1, L-carnitine, substrate and inhibitor of organic cation transporter OCTN1 and OCTN2, and choline, substrate and inhibitor of organic cation transporter OCTN1, OCTN2, and OCT1 (Table 1) , and were significantly increased by preloading with them (Table 2 ). These findings demonstrate that PEPT1, OCTN1, and OCTN2 on the apical membrane in Caco-2 cells take part in the apical-to-basolateral transport (absorption process) of sulpiride.
On the other hand, the basolateral-to-apical transport of sulpiride was significantly inhibited, and the intracellular accumulation of sulpiride from the basolateral side was significantly increased by the addition of cyclosporin A (Table 1) . Furthermore, the basolateral-to-apical transport of sulpiride was significantly increased by preloading with cyclosporin A ( Table 2 ). The basolateral-to-apical transport of sulpiride and its intracellular accumulation from the basolateral side were significantly inhibited by the addition of choline, inhibitor of organic cation transporter OCT1, OCTN1, and OCTN2, and quinidine and verapamil, substrates of P-glycoprotein and organic cation transporters OCTN1, OCTN2, and OCT1 (Table  1) , and were significantly increased by preloading with them (Table 2) . However, L-carnitine, substrate and inhibitor of organic cation transporters OCTN1 and OCTN2, had no significant effect on the basolateral-to-apical transport of sulpiride and its intracellular accumulation from the basolateral side.
From these findings, we presume that OCT1 on the basolateral membrane and P-glycoprotein on the apical membrane take part in the basolateral-to-apical transport (secretion process) of sulpiride.
Caco-2 cells possess the H ϩ /dipeptide cotransport system (PEPT1) in the apical membrane. 27) Recently, Terada and coworkers 9) have suggested that a single facilitative peptide transporter is expressed at the basolateral membranes of Caco-2 cells, and that PEPT1 and the basolateral peptide transporter cooperate in the efficient transepithelial transport of small peptides and peptide-like drugs. The remarkable findings of the inhibition of the intracellular accumulation of sulpiride from the basolateral side by the addition of captopril, cephalexin, and glycylsarcosine, and its enhancement by preloading with them, indicate that a basolateral facilitative peptide transporter is involved in the intracellular accumulation of sulpiride from the basolateral side. It is possible that the intestinal transport of sulpiride is similar to the mechanism proposed by Terada and coworkers. 9) The intestinal secretion systems of organic cation compounds have been described in several studies. 10, 12) At least two transport systems, P-glycoprotein and organic cation transporters, play an important role in the secretion of organic cation compounds across the apical membrane. The results of the present study suggest that sulpiride is also excreted from the small intestine through an efflux pump such as P-glycoprotein and the organic cation transporter OCT1. This could be one of the reasons why the bioavailability of sulpiride in humans after oral administration is low with a mean value of 27%. 28) Baluom and coworkers 29) reported that sulpiride intestinal absorption was increased when administered together with verapamil and quinidine. They speculated that the poor oral bioavailability of sulpiride was caused by P-glycoprotein efflux on the brush-border membrane. The results in the present study correspond to a part of the results in Baluom et al.'s report.
Sulpiride is widely used for the treatment of schizophrenia, depression, and gastric and duodenal ulcers. 3, 4) The importance of maintaining a therapeutic concentration of sulpiride in the blood must be emphasized for effective pharmacological action. A decrease in the absorption of sulpiride may occur in coadministration protocols involving PEPT1-, OCTN1-, and OCTN2-transported drugs. Conversely, coadministration with the P-glycoprotein-and OCT1-transported drugs may enhance the absorption of sulpiride. Further studies both in situ and in vivo will be undertaken to shed light on such putative drug-drug interactions. In conclusion, the present results demonstrate that the apical-to-basolateral transport (absorption) of sulpiride across human intestinal Caco-2 cells is mediated by the transport systems of peptide and organic cation, while the reverse transport (secretion) is mediated by the transport systems of P-glycoprotein and organic cation. The existence of other sulpiride transport systems in Caco-2 cells was considered, but we finally proposed that sulpiride is transported by the process shown in Fig. 3 from the findings of the present study. 
